Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.1
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock
APIC
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Non-Controlling Interest
Total
Balance at Dec. 31, 2019 $ 965 $ 118,179,635 $ (104,597,748) $ (11,250) $ (413,752) $ 13,157,850
January 2020 investment offering, net of underwriters discounts 571 4,105,577       4,106,148
Issued under ATM, net of issuance costs 371 11,427,864       11,428,235
Issuance of common stock from vesting of restricted stock awards 47 (47)        
Stock issuance costs   (452,934)       (452,934)
Stock based compensation   948,192       948,192
Exercise of warrants 214 2,724,395       2,724,609
Exchange of warrants 64 773,266       773,330
Other comprehensive income (loss)       218,804   218,804
Net loss     (6,292,106)   (81,314) (6,373,420)
Balance at Mar. 31, 2020 2,232 137,705,948 (110,889,854) 207,554 (495,066) 26,530,814
Balance at Dec. 31, 2020 4,519 247,048,349 (130,647,485) (166,056) (745,404) 115,493,923
Issued under ATM, net of issuance costs 420 26,303,862       26,304,282
Issuance of common stock from vesting of restricted stock awards 82 (82)        
Stock issuance costs   (658,184)       (658,184)
Stock based compensation   2,897,580       2,897,580
Issuance of restricted stock 3 (3)        
Exercise of options 6 27,255       27,261
Cancellation and payout of fractional shares (3) 3        
Other comprehensive income (loss)       18,268   18,268
Net loss     (7,532,178)   (90,962) (7,623,140)
Balance at Mar. 31, 2021 $ 5,027 $ 275,618,780 $ (138,179,663) $ (147,788) $ (836,366) $ 136,459,990